Founder and CEO of KLOTHO SKIN discusses the Klotho longevity protein, regenerative skincare, clinical research, and the future of health. See the full video at the bottom of this article.
BELLEVUE, WA — October 23, 2026 — Longevity Academy recently welcomed Dr. Gail Humble, founder and CEO of KLOTHO SKIN and co-founder of Klotho Longevity, to the Longevity Leaders Project, an ongoing interview series exploring the people, organizations, and scientific breakthroughs shaping the future of human longevity.
Hosted by Rick Diamond, CEO of Longevity Academy, the conversation explored the growing body of research surrounding the Klotho gene and protein, their potential role in cellular aging, and how KLOTHO SKIN is applying this science to regenerative skincare.
Dr. Humble has been studying the Klotho protein for nearly three decades. With a background in genetics and regenerative aesthetics, she became interested in its potential shortly after the gene was first identified in 1997.
Originally studied for its relationship to aging and age-related diseases, Klotho has since attracted growing attention for its involvement in cellular protection, oxidative stress regulation, and multiple biological pathways associated with healthy aging.
During the interview, Dr. Humble explained how Klotho protein levels generally decline with age and why researchers are increasingly interested in understanding whether maintaining or increasing these levels could help support healthier aging.
Rather than simply addressing visible signs of aging, KLOTHO SKIN is investigating how cellular processes associated with aging might be influenced through regenerative skincare.
A central focus of the discussion was the company’s clinical research. Dr. Humble presented findings from laboratory studies and three human clinical studies evaluating skincare formulations containing Klotho protein and growth factors derived from conditioned stem cell media.
In one laboratory study, treated cells demonstrated a 40% reduction in DNA strand damage following ultraviolet exposure compared with controls.
Dr. Humble also highlighted findings from the company’s human studies, including reported improvements in photodamage, skin texture, wrinkles, dryness, and uneven pigmentation. In a 16-patient study involving a layered skincare regimen over four months, researchers reported a 47.5% reduction in photodamage and a 61% reduction in dryness.
While these early findings are promising, the studies involved relatively small groups, and further research will be important to establish the long-term benefits and broader clinical applications of Klotho-based skincare.
The discussion also explored the relationship between skin aging and biological aging throughout the body. Dr. Humble emphasized that skin is more than a cosmetic concern. As the body’s largest organ, it plays essential roles in protection, immune function, temperature regulation, and overall health.
The conversation covered several key topics:
- How Dr. Gail Humble became interested in the Klotho gene and protein and began researching its potential nearly 30 years ago
- The relationship between Klotho protein levels, cellular aging, oxidative stress, and age-related diseases
- How KLOTHO SKIN is applying regenerative science to support skin health and address visible signs of aging
- Findings from laboratory and human clinical studies evaluating Klotho-based skincare formulations
- The potential connection between skin aging, biological age, and overall healthspan
- The importance of exercise, sleep, stress management, and other lifestyle factors in supporting healthy aging
- Emerging research involving Klotho supplementation, gene-based technologies, and future longevity interventions
- How regenerative dermatology may evolve as researchers better understand the biological mechanisms of aging
Looking ahead, Dr. Humble discussed Klotho Longevity’s interest in developing an oral Klotho protein supplement, while acknowledging the scientific and delivery challenges involved. She also described emerging research into other approaches designed to influence Klotho activity.
The interview highlighted an important shift taking place within longevity science: growing interest in addressing the biological mechanisms of aging rather than focusing exclusively on its visible effects or individual age-related conditions.
For Dr. Humble, protecting skin health is an important part of that broader mission.
Part of the Longevity Leaders Project
The Longevity Leaders Project, created by Longevity Academy, features conversations with entrepreneurs, researchers, executives, innovators, and thought leaders working across the rapidly expanding longevity ecosystem.
Rather than focusing only on individual products or technologies, the series examines the people behind longevity innovation, the problems they are trying to solve, the lessons they have learned, and their vision for the future of human health and lifespan.
Previous Longevity Leaders Project conversations have featured leaders from organizations including Longevity Advice, Global Health Atlas, JouleFit, BrainBoosters of America, and Respira Global.
The conversation with Dr. Gail Humble continues the project’s mission of documenting the people and organizations helping transform longevity from an emerging scientific field into a global movement.
Watch the full interview: Longevity Leaders Project
Exclusive KLOTHO SKIN Discount for Longevity Academy Readers
Interested in exploring the science behind KLOTHO SKIN for yourself? Longevity Academy readers can enjoy 10% off KLOTHO SKIN products using the exclusive discount code DIAMOND10.
Visit ClothoSkin.com and enter DIAMOND10 at checkout to receive your discount.
About Dr. Gail Humble and KLOTHO SKIN
Dr. Gail Humble is the founder and CEO of KLOTHO SKIN and co-founder of Klotho Longevity. With a background in genetics and regenerative aesthetics, she has spent nearly three decades investigating the Klotho protein and its potential applications in healthy aging.
KLOTHO SKIN develops regenerative skincare formulations incorporating Klotho protein and growth factors produced through a proprietary cell conditioning process. The company has conducted laboratory research and human clinical studies examining potential improvements in skin appearance, photodamage, and other markers of skin aging.
Through its ongoing research, KLOTHO SKIN aims to advance the relationship between cellular science, dermatology, and longevity medicine.
Learn more about KLOTHO SKIN at ClothoSkin.com.
About Longevity Academy
Longevity Academy is an educational platform focused on helping people understand the science, technologies, companies, and individuals shaping the future of healthy longevity.
Through educational resources and initiatives such as the Longevity Leaders Project, Longevity Academy connects audiences with innovators working to extend healthspan, improve quality of life, and advance the emerging longevity economy.
Learn more at LongevityAcademy.us.